IP Library Granted Patent US 9,790,486
Granted Patent B2
US 9,790,486 · App. 14/591,291 · Granted Oct 17, 2017

Methods and compositions for segregating target nucleic acid from mixed nucleic acid samples

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,790,486
App. No.
14/591,291
Granted
Oct 17, 2017
Kind
B2
Abstract

The invention provides methods, compositions and kits for segregating a target nucleic acid from a mixed nucleic acid sample. The methods, compositions and kits comprise a non-processive endonuclease (e.g., a restriction enzyme) or an antibody that binds the target nucleic acid (e.g., has methylation specificity). The mixed nucleic acid sample can comprise prokaryotic and eukaryotic nucleic acid and/or nucleic acid from more than one prokaryotic or eukaryotic organisms.

Claims (36)

1. A composition for segregating a target nucleic acid from a mixed sample containing a target nucleic acid and a non-target nucleic acid, comprising:

(i) a non-processive endonuclease that binds to the target nucleic acid, but does not cleave the target nucleic acid; and

(ii) a buffer having conditions suitable for the non-processive endonuclease to bind the target nucleic acid, but not cleave the target nucleic acid;

wherein the buffer contains EDTA at a concentration of at least 10 mM.

2. The composition of claim 1 , further comprising:

(iii) a mixed sample comprising a target nucleic and a non-target nucleic acid.

3. The composition of claim 2 , wherein the mixed sample contains at least 100,000 times the amount of non-target nucleic acid compared to the amount of target nucleic acid.

4. The composition of claim 2 , wherein the mixed sample contains less than 10 pg of target nucleic acid.

5. The composition of claim 2 , wherein the mixed sample further comprises humic acid, diesel soot, or an environmental or clinical contaminant.

6. The composition of claim 1 , wherein the non-processive endonuclease has less than 10% of the catalytic activity of a control endonuclease that binds the target nucleic acid and cleaves the target nucleic acid.

7. The composition of claim 1 , wherein the buffer contains a Ca2+ concentration of at least 50 mM.

8. The composition of claim 1 , wherein the buffer contains a Mg2+ concentration of less than 10 mM.

9. A composition for segregating a target nucleic acid from a mixed sample containing a target nucleic acid and a non-target nucleic acid, comprising:

(i) a non-processive endonuclease that binds to the target nucleic acid, but does not cleave the target nucleic acid; and

(ii) a buffer having conditions suitable for the non-processive endonuclease to bind the target nucleic acid, but not cleave the target nucleic acid;

wherein the non-processive endonuclease is a non-processive restriction enzyme.

10. The composition of claim 9 , further comprising:

(iii) a mixed sample comprising a target nucleic and a non-target nucleic acid.

11. The composition of claim 10 , wherein the mixed sample contains at least 100,000 times the amount of non-target nucleic acid compared to the amount of target nucleic acid.

12. The composition of claim 10 , wherein the mixed sample contains less than 10 pg of target nucleic acid.

13. The composition of claim 10 , wherein the mixed sample further comprises humic acid, diesel soot, or an environmental or clinical contaminant.

14. The composition of claim 9 , wherein the non-processive endonuclease has less than 10% of the catalytic activity of a control endonuclease that binds the target nucleic acid and cleaves the target nucleic acid.

15. The composition of claim 9 , wherein the buffer contains a Ca2+ concentration of at least 50 mM.

16. The composition of claim 9 , wherein the buffer contains a Mg2+ concentration of less than 10 mM.

17. A composition for segregating a target nucleic acid from a mixed sample containing a target nucleic acid and a non-target nucleic acid, comprising:

(i) a non-processive endonuclease that binds to the target nucleic acid, but does not cleave the target nucleic acid; and

(ii) a buffer having conditions suitable for the non-processive endonuclease to bind the target nucleic acid, but not cleave the target nucleic acid;

wherein the non-processive endonuclease is DpnI.

18. The composition of claim 17 , further comprising:

(iii) a mixed sample comprising a target nucleic and a non-target nucleic acid.

19. The composition of claim 18 , wherein the mixed sample contains at least 100,000 times the amount of non-target nucleic acid compared to the amount of target nucleic acid.

20. The composition of claim 18 , wherein the mixed sample contains less than 10 pg of target nucleic acid.

21. The composition of claim 18 , wherein the mixed sample further comprises humic acid, diesel soot, or an environmental or clinical contaminant.

22. The composition of claim 17 , wherein the non-processive endonuclease has less than 10% of the catalytic activity of a control endonuclease that binds the target nucleic acid and cleaves the target nucleic acid.

23. The composition of claim 17 , wherein the buffer contains a Ca2+ concentration of at least 50 mM.

24. The composition of claim 17 , wherein the buffer contains a Mg2+ concentration of less than 10 mM.

Assignments (4)
CHANGE OF NAME Recorded Dec 21, 2023
From: TELEDYNE FLIR DETECTION, INC.
To: TELEDYNE FLIR DEFENSE, INC.
Reel/Frame 066089/0781 →
CHANGE OF NAME Recorded Dec 21, 2023
From: FLIR DETECTION, INC.
To: TELEDYNE FLIR DETECTION, INC.
Reel/Frame 066089/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2015
From: FLIR SYSTEMS, INC.
To: FLIR DETECTION, INC.
Reel/Frame 036140/0405 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2015
From: FORSYTH, ROGER ALLYN
To: FLIR SYSTEMS, INC.
Reel/Frame 035248/0956 →